114 related articles for article (PubMed ID: 17245425)
21. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
22. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
[TBL] [Abstract][Full Text] [Related]
23. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
24. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
26. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
27. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy.
Mahdi-Rogers M; Kazmi M; Ferner R; Hughes RA; Renaud S; Steck AJ; Fuhr P; Halter J; Gratwohl A; Tyndall A
J Peripher Nerv Syst; 2009 Jun; 14(2):118-24. PubMed ID: 19691534
[TBL] [Abstract][Full Text] [Related]
28. Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation.
Yazaki M; Atsuta Y; Kato K; Kato S; Taniguchi S; Takahashi S; Ogawa H; Kouzai Y; Kobayashi T; Inoue M; Kobayashi R; Nagamura-Inoue T; Azuma H; Takanashi M; Kai S; Nakabayashi M; Saito H;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):439-46. PubMed ID: 19285631
[TBL] [Abstract][Full Text] [Related]
29. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
Liu H; Ding JH; Liu BC; Zhao G; Chen BA
Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
[TBL] [Abstract][Full Text] [Related]
30. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
31. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
32. Bloodstream infection after living donor liver transplantation.
Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Makuuchi M
Scand J Infect Dis; 2008; 40(6-7):509-16. PubMed ID: 18584539
[TBL] [Abstract][Full Text] [Related]
33. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
35. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Nieboer P; de Vries EG; Mulder NH; Rodenhuis S; Bontenbal M; van der Wall E; van Hoesel QG; Smit WM; Hupperets P; Voest EE; Nooij MA; Boezen HM; van der Graaf WT
Bone Marrow Transplant; 2008 Oct; 42(7):475-81. PubMed ID: 18622420
[TBL] [Abstract][Full Text] [Related]
37. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Bone Marrow Transplant; 2007 Dec; 40(11):1055-62. PubMed ID: 17891187
[TBL] [Abstract][Full Text] [Related]
39. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
